Daratumumab, bortezomib, and dexamethasone in relapsed or...

Journal of Hematology & Oncology 2020 / 12 Vol. 13; Iss. 1

Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: subgroup analysis of CASTOR based on cytogenetic risk

Weisel, Katja, Spencer, Andrew, Lentzsch, Suzanne, Avet-Loiseau, Hervé, Mark, Tomer M., Spicka, Ivan, Masszi, Tamas, Lauri, Birgitta, Levin, Mark-David, Bosi, Alberto, Hungria, Vania, Cavo, Michele,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Journal:
Journal of Hematology & Oncology
DOI:
10.1186/s13045-020-00948-5
Date:
December, 2020
File:
PDF, 883 KB
2020
Conversion to is in progress
Conversion to is failed